Formulation, characterization and release studies of alginate microspheres encapsulated with tetanus toxoid

Journal of Biomaterials Science, Polymer Edition

Volumn 17, Issue 8, 2006, Pages 909-924

  Tafaghodi, M ^a,b   Sajadi Tabasi, S A ^a,c   Jaafari, M R ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Alginate; Characterization; Microsphere; Preparation; Tetanus toxoid

Indexed keywords

ANTIGENS; CALCIUM COMPOUNDS; EMULSIFICATION; ENCAPSULATION; POROSITY; SURFACE ROUGHNESS;

ALGINATE MICROSPHERES; SONICATION; SPHERICITY; TETANUS TOXOID;

POLYSACCHARIDES;

ALGINIC ACID; CALCIUM ALGINATE; CALCIUM CHLORIDE; EMULSIFYING AGENT; MICROSPHERE; OCTANOL; SURFACTANT; TETANUS TOXOID;

ANALYZER; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG ANTIGENICITY; DRUG DELIVERY SYSTEM; DRUG SOLUBILITY; EMULSION; ENCAPSULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOREACTIVITY; MICROSCOPY; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; ULTRASOUND;

1-OCTANOL; ALGINATES; BIOCOMPATIBLE MATERIALS; CALCIUM CHLORIDE; DELAYED-ACTION PREPARATIONS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG STABILITY; GLUCURONIC ACID; HEXURONIC ACIDS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; MICROSPHERES; MUCOUS MEMBRANE; PARTICLE SIZE; SOLUTIONS; SONICATION; SURFACE-ACTIVE AGENTS; TETANUS TOXOID;

EID: 33747356282     PISSN: 09205063     EISSN: None     Source Type: Journal    
DOI: 10.1163/156856206777996880     Document Type: Article

References (25)

1. W. R. Gombotz and S. Wee, Adv. Drug Deliv. Rev. 31, 267 (1998).
2. S. Al-Musa, D. Abu Fara and A. A. Badwan, J. Control. Rel. 57, 223 (1999).
3. A. Esquisabel, R. M. Hernandez, M. Igartua, A. R. Gascon, B. Calvo and J. L. Pedraz, J. Microencap. 14, 627 (1997).
4. V. Pillay and R. Fassihi, J. Control. Rel. 59, 243 (1999).
5. M. C. Rebelatto, P. Guimond, T. L. Bowersock and H. Hogen-Esch, Vet. Immunol. Immunopathol. 83, 93 (2001).
6. T. L. Bowersock, H. Hogen-Esch, M. Suckow, R. E. Porter, R. Jackson, H. Park and K. Park, J. Control. Rel. 39, 209 (1996).
7. T. L. Bowersock, H. Hogen-Esch, S. Torregrosa, D. Borie, B. Wang, H. Park and K. Park, Immunol. Lett. 60, 37 (1998).
8. N.-H. Cho, S.-Y. Seong, K.-H. Chun, Y.-H. Kim, I. C. Kwon, B.-Y. Ahn and S. Y. Jeong, J. Control. Rel. 53, 215 (1998).
9. G. W. Vandenberg, C. Drolet, S. L. Scott and J. de la Noue, J. Control. Rel. 77, 297 (2001).
10. R. M. Carr, C. M. Lolachi, R. G. Albaran, D. M. Ridley, P. C. Montgomery and N. L. O'sullivan, Immunol. Invest. 25, 387 (1996).
11. D. Lemoine, F. Wauters, S. Bouchend'homme and V. Preat, Int. J. Pharm. 176, 9 (1998).
12. D. T. O'Hagan, J. Anat. 189, 477 (1996).
13. A. T. Florence, Pharm. Res. 14, 259 (1997).
14. B. O. Stuart, Environ. Health Perspect. 55, 369 (1984).
15. J. M. Payne, B. F. Sansom, R. J. Garner, A. R. Thomson and B. J. Miles, Nature 188, 586 (1960).
16. K. S. Chen and G. V. Quinnan, Jr., J. Gen. Virol. 70, 3291 (1989).
17. J. E. Eyles, E. D. Williamson and H. O. Alpar, Int. J. Pharm. 189, 75 (1999).
18. L. S. C. Wan, P. W. S. Heng and L. W. Chan, in: Proceedings of the NUS-JSPS. Seminar on Recent Developments in Pharmaceutics and Pharmaceutical Technology, Japan, Chiba University, p. 243 (1990).
19. H. Jeffery, S. S. Davis and D. T. O'Hagan, Int. J. Pharm. 77, 169 (1991).
20. A. Dashevsky, Int. J. Pharm. 161, 1 (1998).
21. K. Tateshita, S. Sugawara, T. Imai and M. Otagiri, Biol. Pharm. Bul. 16, 420 (1993).
22. S. Sugawara, T. Imai and M. Otagiri, Pharm. Res. 11, 272 (1994).
23. A. Kikuchi, M. Kawabuchi, A. Watanabe, M. Sugihara, Y. Sakurai and T. Okano, J. Control. Rel. 58, 21 (1999).
24. L. W. Chan, P. W. Heng and L. S. Wan, J. Microencap. 14, 545 (1997).
25. A. J. Almeida and H. O. Alpar, in: Antigen Delivery Systems, B. Gander and H. P. Merkle (Eds), p. 207. Harwood, New York, NY (1997).